Tyler Cannon

Tyler Cannon

Auto-generated profile, based on publicly available information

Tyler Cannon

Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2019 in Nature
Verified
Journal Article
Closed access
DMDiana Matheoud
Diana Matheoud
TCTyler Cannon
Tyler Cannon
AVAurore Voisin
Aurore Voisin
APAnna-Maija Penttinen
Anna-Maija Penttinen
LRLauriane Ramet
Lauriane Ramet
MDMichel Desjardins
Michel Desjardins

16 October 2020 in Gut Microbes
Verified
Journal Article
Open access
TCTyler Cannon
Tyler Cannon
ASAnshul Sinha
Anshul Sinha
LTLouis-Eric Trudeau
Louis-Eric Trudeau
CMCorinne Maurice
Corinne Maurice
SGSamantha Gruenheid
Samantha Gruenheid
Parkinson’s disease (PD) is a neurodegenerative disorder that has been shown to be influenced by the intestinal milieu. The gut microbiota is altered in PD patients, and murine studies have begun suggesting a causative role for the gut microbiota in progression of PD. We have previously shown that repeated infection with the intestinal murine pathogen Citrobacter rodentium resulted in the development of PD-like pathology in Pink1 −/- mice compared to wild-type littermates. This addendum aims to expand this work by characterizing the gut microbiota during C. rodentium infection in our Pink1 −/- PD model. We observed little disturbance to the fecal microbiota diversity both between infection timepoints and between Pink1 −/- and wild-type control littermates. However, the level of short-chain fatty acids appeared to be altered over the course of infection with butyric acid significantly increasing in Pink1 −/- mice and isobutyric acid increasing in wild-type mice.

15 June 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AFAhmed M. Fahmy
Ahmed M. Fahmy
TCTyler Cannon
Tyler Cannon
CPCamberly Herdandez Paredes
Camberly Herdandez Paredes
AAAli Ahmadi
Ali Ahmadi
YXYong Zhong Xu
Yong Zhong Xu
MDMichel Desjardins
Michel Desjardins
While the contribution of inflammation in the pathological process leading to Parkinson’s disease (PD) is well established, a growing body of evidence supports a role for the long-lasting adaptive immune system in the disease. We showed that, in inflammatory conditions, the PD-proteins PINK1 and Parkin negatively regulate the presentation of mitochondrial antigens on MHC I molecules, a process referred to as MitAP ( Mit ochondrial A ntigen P resentation). In the absence of PINK1, over-activation of this pathway in antigen-presenting cells (APCs) engages autoimmune mechanisms leading to the establishment of cytotoxic CD8 + T cells. Co-culture of dopaminergic neurons (DNs) with these T cells led to neuronal cell death, suggesting that the MitAP in DNs made them susceptible to T cell-mediated destruction. In the present study, we used a pharmacological and genetic approach to characterize the MitAP pathway at the molecular level. We showed that this antigen presentation pathway is induced in APCs in response to inflammatory signals through the sequential activation of TLR4, cGAS-STING and the Unfolded Protein Response (UPR). A “UPR motif” present on a STING cytoplasmic domain was shown to specifically activate the UPR sensor IRE1. Remarkably, the PD-related protein LRRK2, acted with STING upstream of the UPR to regulate the transition from innate to adaptive immunity, thereby identifying this PD-related protein as a key player in the immune response during inflammation.

11 June 2026 in Cell Reports
Verified
Journal Article
Open access
AFAhmed M. Fahmy
Ahmed M. Fahmy
AAAli Ahmadi
Ali Ahmadi
JLJoel Lanoix
Joel Lanoix
TCTyler Cannon
Tyler Cannon
MEMoustafa N. Elemeery
Moustafa N. Elemeery
MDMichel Desjardins
Michel Desjardins
A growing body of evidence supports the contribution of the long-lasting adaptive immune system in Parkinson's disease (PD). We showed that the PD-associated protein PINK1 negatively regulates the presentation of mitochondrial antigens (MitAP) on MHC-I molecules. In vivo evidence indicated that MitAP activation in mice, in the absence of PINK1, led to cytotoxic CD8+ T cell stimulation and severe motor impairments, reversible by L-DOPA. We show here that following TLR4 activation, MitAP is engaged through a pathway involving cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING), which acts as a rheostat to dampen the unfolded protein response (UPR). Without STING, the stress response is amplified, leading to a translational attenuation that inhibits the expression of XBP1s, a transcription factor required for MitAP. STING activity also regulates the repertoire of peptides displayed at the cell surface during inflammation, highlighting a potential role in immunosurveillance. These findings establish STING and the UPR as key immune regulators targetable for therapeutic intervention during autoimmune diseases and PD.

28 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
AFAhmed M. Fahmy
Ahmed M. Fahmy
AAAli Ahmadi
Ali Ahmadi
JLJoel Lanoix
Joel Lanoix
TCTyler Cannon
Tyler Cannon
MEMoustafa Nouh Badr Elemeery
Moustafa Nouh Badr Elemeery
MDMichel Desjardins
Michel Desjardins
Summary: A growing body of evidence supports the contribution of the long-lasting adaptive immune system in Parkinson’s disease (PD). We showed that the PD-associated protein PINK1 negatively regulates the presentation of mitochondrial antigens (MitAP) on MHC-I molecules. In vivo evidence indicated that MitAP activation in mice, in the absence of PINK1, led to cytotoxic CD8 + T cell stimulation and severe motor impairments, reversible by L-DOPA. We show here that following TLR4 activation, MitAP is engaged through a pathway involving cGAS-STING, which acts as a rheostat to dampen the unfolded protein response (UPR). Without STING, the stress response is amplified, leading to a translational attenuation that inhibits the expression of XBP1s, a transcription factor required for MitAP. STING activity also regulates the repertoire of peptides displayed at the cell surface during inflammation, highlighting a potential role in immunosurveillance. These findings establish STING and the UPR as key immune regulators targetable for therapeutic intervention during autoimmune diseases and PD.

24 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSriparna Mukherjee
Sriparna Mukherjee
VGVladimir Grouza
Vladimir Grouza
ATAlex Tchung
Alex Tchung
AEAmandine Even
Amandine Even
MYMoein Yaqubi
Moein Yaqubi
LTLouis-Eric Trudeau
Louis-Eric Trudeau
A growing body of research suggests a link between immune system activation and the development of Parkinson’s disease (PD). Previous work showed that repeated gastrointestinal infection with Citrobacter rodentium can induce PD-like motor dysfunction in Pink1 knockout (KO) mice, along with immune cell infiltration into the brain. To better understand mechanisms underlying immune-mediated brain attack in this model, we tested whether mild infections are sufficient to increase blood-brain barrier (BBB) permeability and trigger brain inflammation. Pink1 wild-type (WT) and KO mice were infected with C. rodentium , and gadolinium-enhanced magnetic resonance imaging (MRI) was performed at days 13 and 26 post-infection to assess BBB integrity. Quantitative MRI analysis revealed increased BBB permeability at day 26 in both WT and KO mice, particularly in the striatum, dentate gyrus, somatosensory cortex, and thalamus. Notably, this permeability was not associated with changes in tight junction protein expression or dopamine system markers in the striatum at either time point. However, persistent microglial activation was observed at day 26 post-infection, along with elevated levels of inflammatory mediators such as eotaxin, IFN-γ, CXCL9, IL-17, and MIP-2 in the striatum. Additionally, serum levels of IL-17 and CXCL1 were increased in infected Pink1 KO mice. Flow cytometry revealed neutrophil infiltration in the brain at day 26 post-infection. Finally, a bulk RNA-seq transcriptome analysis revealed that gene sets related to synaptic function were particularly influenced by the infection and that inflammation-related genes were upregulated by the infection in the Pink1 KO mice. These findings support the hypothesis that even mild gastrointestinal infections can increase BBB permeability, disrupt brain homeostasis, and promote chronic neuroinflammation. In genetically susceptible individuals, such as those with Pink1 deficiency, this may represent a first hit that contributes to subsequent induction of PD pathology with aging. Author summary: We hypothesize that immune system activation is linked to the development of Parkinson’s disease (PD). Previous work revealed that repeated gastrointestinal infections with Citrobacter rodentium causes PD-like symptoms and immune cell invasion in the brain of Pink1 knockout (KO) mice. In the current study, we tested whether a single mild gut infection alters blood-brain barrier (BBB) permeability and causes brain inflammation. We infected Pink1 WT and KO mice with Citrobacter rodentium and used gadolinium-enhanced MRI to detect BBB permeability changes at 13- and 26-days post-infection. Results showed increased BBB permeability in specific brain regions at 26 days. While tight-junction and dopamine (DA)-related proteins remained unchanged, we observed altered expression of synaptic genes, chronic microglial activation, elevated inflammatory markers, and neutrophil infiltration in the brain. Our findings suggest that even mild gastrointestinal infections can increase BBB permeability, potentially enabling immune cell infiltration into the brain and exacerbating pathways implicated in the development of PD, particularly among individuals with genetic risk factors.